ascopubs.org

Prospective comparison of subcutaneous to intravenous administration of bortezomib in patients with multiple myeloma: Pharmacokinetics, efficacy and toxicity

The benefit of reduced intensity conditioning (RIC) allogeneic stem cell transplantation (allo-SCT) as salvage treatment for relapsing multiple myeloma (MM) Bortezomib (Bz) is a novel proteasome ...
Monthly Prescribing Reference

Intelliport System Cleared to Improve IV Bolus Management

Intelliport System Cleared to Improve IV Bolus Management BD announced that the Food and Drug Administration (FDA) has cleared the BD Intelliport Medication Management System, a management system for ...
ascopubs.org

VAD (vincristine, doxorubicin and high-dose dexamethasone) administered as intravenous bolus (IVB) injection as first-line treatment in multiple myeloma (MM)

A phase I/IIa clinical trial of CLAOP21 and CLAOP14 in patients with high-grade non-Hodgkin's lymphoma and cardiac risk factors No significant financial relationships to disclose. This is an ASCO ...